Sox17 required for steps from embryonic to heart muscle cell

February 26, 2007

An important choreographer of the complicated dance of signals, enzymes and proteins that takes embryonic stem cells through the steps to becoming a beating heart muscle cell is the gene Sox17, said researchers from Baylor College of Medicine in a report in the current issue of the Proceedings of the National Academy of Sciences.

To be precise, Sox17 is critical in transforming primitive mesoderm (an early layer of tissue in the embryo) into the more specialized cardiac mesoderm from which heart muscle develops, said Dr. Michael Schneider, senior researcher of the report.

"Heart muscle formation by embryonic stem cells is a complex, multi-step process," said Schneider, professor of medicine, molecular and cellular biology, and molecular physiology and biophysics at Baylor College of Medicine. "We have succeeded in uncoupling the formation of cardiac mesoderm from its antecedent steps. That discovery provides immediate insight into how one might seek to generate cardiac muscle more effectively from embryonic stem cells."

"One of the major challenges is the very meager ability of the heart muscle to restore itself after cell death," said Schneider. Heart muscle cells die acutely during heart attacks and sporadically in chronic heart failure.

"Identifying stem cells that can be encouraged along the path to becoming heart muscle is a paramount scientific goal," he said.

Embryonic stem cells are a potential source because they have the potential of becoming every type of cell in the body. However, much research remains before scientists can outline a blueprint for how these totally undifferentiated cells can be guided to the "fate" of becoming heart muscle selectively.

Schneider and his colleagues used proteins that block certain signals for cell specialization at the surface of mouse embryonic stem cells to pinpoint early steps that lead to the development of heart muscle. Then, using "gene chip" technology to measure the expression of 40,000 mouse genes simultaneously, Schneider and his colleagues identified the sudden expression of Sox17 as a potentially important step for the signals that lead to heart formation.

Using a technique called RNA interference, they then blocked the action of Sox17 in the embryonic stem cells. By doing so, they prevented the embryonic cells from becoming cardiac muscle, almost completely.

"Knocking down Sox17 (reducing expression of the gene) had a dramatic effect, both on genes for structural components of the heart and also genes for transcription factors that turn on the cardiac fate," said Schneider.
-end-
Others who took part in the research include: Drs. Yu Liu, Masanori Asakura, Hironori Inoue, Teruya Nakamura, Motoaki Sano and Zhiyv Niu of BCM, Michelle Chen of Agilent Technologies in Santa Clara, California; and Robert J. Schwartz of the Institute of Biosciences and Technology at Texas A&M University Health Science Center in Houston.

Funding for this work came from the National Institutes of Health, the M. D. Anderson Foundation Chair, and the Fondation Leducq Transatlantic Network of Excellence for Cardiovascular Research.

Baylor College of Medicine

Related Embryonic Stem Cells Articles from Brightsurf:

New mechanisms that regulate pluripotency in embryonic stem cells are discovered
A study by researchers at the Center for Cell-Based Therapy, which is supported by FAPESP, identified microRNAs involved in pluripotency maintenance and cell differentiation.

Embryonic mammary gland stem cells identified
Research team led by Prof. C├ędric Blanpain identified the mechanisms that regulate mammary gland development.

New insights into mechanisms regulating gene expression in embryonic stem cells
Researchers from Turku, Finland, have discovered new information about the mechanisms which maintain gene activity in human embryonic stem cells.

New tools to study the origin of embryonic stem cells
Researchers at Karolinska Institutet have identified cell surface markers specific for the very earliest stem cells in the human embryo.

Scientists approve the similarity between reprogrammed and embryonic stem cells
Researchers from the Vavilov Institute of General Genetics, Research Institute of Physical Chemical Medicine and Moscow Institute of Physics and Technology (MIPT) have concluded that reprogramming does not create differences between reprogrammed and embryonic stem cells.

Drug makes stem cells become 'embryonic' again
If you want to harness the full power of stem cells, all you might need is an eraser -- in the form of a drug that can erase the tiny labels that tell cells where to start reading their DNA.

Oncogene controls stem cells in early embryonic development
Many animal species delay the development of their embryos to ensure that their offspring is born at a favorable time.

Are embryonic stem cells and artificial stem cells equivalent?
Harvard Stem Cell Institute (HSCI) researchers at Massachusetts General Hospital and Harvard Medical School have found new evidence suggesting some human induced pluripotent stem cells are the 'functional equivalent' of human embryonic stem cells, a finding that may begin to settle a long running argument.

UCSF researchers control embryonic stem cells with light
UCSF researchers have for the first time developed a method to precisely control embryonic stem cell differentiation with beams of light, enabling them to be transformed into neurons in response to a precise external cue.

Protein plays unexpected role in embryonic stem cells
A protein long believed to only guard the nucleus also regulates gene expression and stem cell development.

Read More: Embryonic Stem Cells News and Embryonic Stem Cells Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.